Flavone acetic acid increases the cytotoxicity of mitomycin C when combined with hyperthermia

Cancer Chemotherapy and Pharmacology

Volumn 38, Issue 1, 1996, Pages 1-8

  Takeuchi, Hideya ^a   Baba, Hideo ^a   Maehara, Yoshihiko ^b   Sugimachi, Keizo ^a,b   Newman, Robert A ^c  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Flavone acetic acid; Hyperthermia; Hypoxia; Mitomycin C; Tumor blood flow

Indexed keywords

MITOFLAXONE; MITOMYCIN C; REDUCING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GRAFT; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; HYPERTHERMIA; HYPOXIA; LASER DOPPLER FLOWMETRY; MALE; MELANOMA B16; MOUSE; MUSCLE BLOOD FLOW; NONHUMAN; PH; PRIORITY JOURNAL; SKELETAL MUSCLE; TUMOR BLOOD FLOW; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL SURVIVAL; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; FLAVONOIDS; HYPERTHERMIA, INDUCED; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MITOMYCIN; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0029979451     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050439     Document Type: Article

References (45)

1. Begg AC, Shrieve DC, Smith KA, Terry NH (1985) Effects of hypoxia, pH, and growth stage on cell killing in Chinese hamster V79 cells in vitro by activated cyclophosphamide. Cancer Res 45:3454
2. Bibby MC, Double JA, Phillips RM, Loadman PM (1987) Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid). Br J Cancer 55:159
3. Bibby MC, Double JA, Loadman PM (1988) Unique chemosensitivity of MAC 16 tumours to flavone acetic acid (LM975, NSC 347512). Br J Cancer 58:341
4. Bull JM, Chretien PB (1976) Editorial: Heat as cancer therapy. J Am Med Assoc 235:2223
5. Carlsson G, Gullberg B, Hafstrom L (1983) Estimation of liver tumor volume using different formulas: an experimental study in rats. J Cancer Res Clin Oncol 105:20
6. Dorr RT, Alberts DS, Liddil JD (1988) Mitomycin C toxicity and pharmacokinetics in mice given sulfur nucleophiles. Anticancer Res 8:733
7. Duke CV, Double JA, Bibby MC (1988) Flavone acetic acid (LM975, NSC 347512) induces rapid massive necrosis in a murine transplantable adenocarcinoma (MAC 26). Br J Cancer 58:532
8. Dulhanty AM, Li M, Whitmore GF (1989) Isolation of Chinese hamster ovary cell mutants deficient in excision repair and mitomycin C bioactivation. Cancer Res 49:117
9. Evelhoch JL, Bissery MC, Chabot GG, Simpson NE, McCoy CL, Heilbrun LK, Corbett TH (1988) Flavone acetic acid (NSC 347512) induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic response spectroscopy. Cancer Res 48:4749
10. Finlay GJ, Smith GP, Fray LM, Baguley BC (1988) Effect of flavone acetic acid on Lewis lung carcinoma; evidence for an indirect effect. J Natl Cancer Inst 80:241
11. Fujimoto S, Kobayashi K, Takahashi M, Konno C, Kokubun M, Ohta M, Shrestha RD, Kiuchi S (1992) Effects on tumour microcirculation in mice of misonidazole and tumour necrosis factor plus hyperthermia. Br J Cancer 65:33
12. Gerweck LE (1977) Modification of cell lethality at elevated temperatures. The pH effect. Radiat Res 70:224
13. Herman TS, Teicher BS, Jochelson M, Clark J, Svensson G, Coleman CN (1988) Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies. Int J Hyperthermia 4:143
14. Hiraoka M, Jo S, Dodo Y, Ono K, Takahashi M, Nishida H, Abe M (1984) Clinical results of radiofrequency hyperthermia combined with radiation in the treatment of radioresistant cancers. Cancer 54:2898
15. Hoban PR, Walton MI, Robson CN, Godden J, Stratford IJ, Workman P, Harris AL, Hickson ID (1990) Decreased NADPH: cytochrome P-450 reductase activity and impaired drug activation in a mammalian cell line resistant to mitomycin C under aerobic but not hypoxic conditions. Cancer Res 50:4692
16. Kennedy KA, Rockwell S, Sartorelli AC (1980) Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells. Cancer Res 40:2356
17. Kennedy KA, Sugar SG, Polomski L, Sartorelli AC (1982) Metabolic activation of mitomycin C by liver microsomes and nuclei. Biochem Pharmacol 31:2011
18. Kerr DJ, Maughan T, Newlands E, Rustin G, Blechen NM, Lewis C, Kaye SB (1989) Phase II trial of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma. Br J Cancer 60:104
19. Keyes SR, Fracasso PM, Heimbrook DC, Rockwell S, Sligar SG, Sartorelli AC (1984) Role of NADPH: cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C. Cancer Res 44:5638
20. Kohnoe S, Emi Y, Takahashi I, Yoshida M, Maehara Y, Sugimachi K (1991) Hypoxia and acidity increase the cytotoxicity of mitomycin C and carboquone to human tumor cells in vitro. Anticancer Res 11:1401
21. Kusumoto T, Maehara Y, Sakaguchi Y, Saku M, Sugimachi K (1989) Hypoxia enhances the lethality of mitomycin C and carboquone against human malignant tumor cells in vitro. Eur Surg Res 21:224
22. Kusumoto T, Maehara Y, Sakaguchi Y, Kohnoe S, Emi Y, Sugimachi K (1991) Sarcoma-180 cells and human colorectal tumor cells under in vitro hypoxic conditions are more sensitive to mitomycin C and carboquone. Eur J Surg Oncol 17:358
23. Lown JW (1979) The molecular mechanism of antitumor action of the mitomycin C. Current status and new development. Academic Press, New York, p 5
24. Mahadevan V, Malik STA, Meager A, Fiers W, Lewis GP, Hart IR (1990) Role of tumor necrosis factor in flavone acetic acid induced tumor vascular shutdown. Cancer Res 50:5537
25. Marshall RS, Paterson MC, Rauth AM (1989) Deficient activation by a human cell strain leads to mitomycin C resistance under aerobic but not hypoxic conditions. Br J Cancer 59:341
26. Murray JC, Smith KA, Thurston G (1989) Flavone acetic acid induces a coagulopathy in mice. Br J Cancer 60:729
27. Murray JC, Smith KA, Stern DM (1991) Flavone acetic acid potentiates the induction of endothelial procoagulant activity by tumor necrosis factor. Eur J Cancer 27:765
28. Nakai M, Tamaki K, Ogata J, Matsui Y, Maeda M (1993) Parasympathetic cerebrovasodilator center of the facial nerve. Circ Res 72:470
29. Nielsen OS, Overgaard J (1977) Effect of extracellular pH on thermotolerance and recovery of hyperthermic damage in vitro. Cancer Res 39:2772
30. Olver IN, Webster LK, Bishop JF, Stokes KH (1992) A phase I and pharmacokinetic study of 12-h infusion of flavone acetic acid. Cancer Chemother Pharmacol 29:354
31. Overgaard J (1976) Influence of extracellular pH on the viability and morphology of tumor cells exposed to hyperthermia. J Natl Cancer Inst 56:1243
32. Overgaard J, Bichel P (1977) The influence of hypoxia and acidity on the hyperthermia response of malignant cells in vitro. Radiology 123:511
33. Plowman J, Narayanan VL, Dykes D, Szarvasi E, Briet P, Yoder OC, Paull KD (1986) Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice. Cancer Treat Rep 70:631
34. Power JA, Harris JW (1977) Response of extremely hypoxic cells to hyperthermia: survival and oxygen enhancement ratios. Radiology 123:767
35. Rockwell S, Kennedy KA (1979) Combination therapy with radiation and mitomycin C: preliminary results with EMT6 tumor cells in vitro and in vivo. Int J Radiat Oncol Biol Phys 5:1673
36. Rubin J, Ames MM, Schutt AJ, Nichols WL, Bowie EJW, Kovach JS (1987) Flavone-8-acetic acid inhibits ristocetin-induced platelet agglutination and prolongs bleeding time. Lancet 7:1081
37. Sakaguchi Y, Maehara Y, Baba H, Kusumoto T, Sugimachi K, Newman RA (1992) Flavone acetic acid increases the antitumor effect of hyperthermia in mice. Cancer Res 52:3306
38. Smith GP, Calveley SB, Smith MJ, Baguley BC (1987) Flavone acetic acid (NSC 347512) induces haemorrhagic necrosis of mouse colon 26 and 38 tumours. Eur J Cancer Clin Oncol 23:1209
39. Stratford IJ, Adams GE, Godden J, Nolan J, Timpson NHN (1988) Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine. Br J Cancer 58:122
40. Sugimachi K, Matsuda H, Ohno S, Fukuda A, Matsuoka H, Mori M, Kuwano H (1988) Long term effects of hyperthermia combined with chemotherapy and irradiation for the treatment of patients with carcinoma of the esophagus. Surg. Gynecol Obstet 167:319
41. Teicher BA, Lazo JS, Sartorelli AC (1981) Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res 41:73
42. Vaupel P, Kallinowski F, Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49:6449
43. Watts ME, Woodcock M (1922) Flavone acetic acid induced changes in human endothelial permeability: potentiation by tumor-conditioned medium. Eur J Cancer 28:1628
44. Wiltrout RH, Boyd MR, Back TC, Salup RR, Arthur JA, Hornung RL (1988) Flavone-8-acetic acid augments systemic natural killer cell activity and synergizes with IL-2 for treatment of murine renal cancer. J Immunol 140:3261
45. Zwi LJ, Baguley BC, Gavin JB, Wilson WR (1990) The use of vascularised spheroids to investigate the action of flavone acetic acid on tumour blood vessels. Br J Cancer 62:231